How to Survive a DEA Inspection Series: For a Research Facility

Page 1

Welcome | Login | Register

Call: 800-447-9407 support@mentorhealth.com

Home

About Us

Category

Webinars

Store

Free Resources

Main How to Survive a DEA Inspection Series: For a Research Facility

Shopping Cart Empty

Product Search Webinar

How to Survive a DEA Inspection Series: For a Research Facility Name : Carlos M. Aquino

Training Options

Product ID : 800027

Thursday, December 1, 2011

Duration: 2 Hours

10:00 AM PST | 01:00 PM EST

Overview The training will cover DEA record-keeping and effective security that DEA registrant must comply with when handling controlled substances. It covers elements of what occurs during an unannounced inspection and the auditing methods.

Live live online training only for one participant

Search By Category

All

6

Speakers

All

6

Month

All

6

Price: $195.00

Corporate Live 4 to 10 participants from a single location (For multiple locations contact Customer

Browse Categories

Hospital

Management

Determining the relationship between the study drug and an AE requires a practiced power of observation & great care (good medical judgment). Determining if an IMP is subject to liver injury separates the best PI's from the rest.

Care)

Why you should attend: It is important to understand stringent DEA regulations required of a Research Lab. This training will give them a better insight on steps to take to maintain required record-keeping and effective security in order to prevent illicit use or diversion of any controlled substance.

Recorded Access recorded version only for one

Medical

participant; unlimited viewing for 6 months

Medicine

Clinical informatics

Price:$695.00

Nursing

( Access information will be emailed 24 hours after the completion of live webinar)

Featured Speakers Price: $245.00

The presentation provides effective record-keeping for purchasing and dispensing of controlled substances for testing or research purposes. Inventory, dispensing, usage and disposal records are part of the accountability process in order to comply with stringent DEA regulations.

Refund Policy

Areas Covered in the Session: l ROLE OF DEA – familiarize the participant with the authority given to DEA when enforcing federal laws and regulations pertaining to controlled substances. l

CIVIL ACTIONS – Briefly describes the civil actions and fines imposed by the U.S Attorney’s Office on a DEA registered Research Lab for failures to comply with DEA record-keeping and security regulations.

l

ADMINISTRATIVE ACTIONS - Provides an insight into the administrative actions that results from violations of stringent DEA regulations imposed on a Research Lab facility.

l

DEA COMPUTATION CHART - Understanding how the audit process is performed by DEA is important in order for the registrant to know what is expected from employees.

l

RECORD-KEEPING REQUIREMENTS - Covers records required by DEA during any unannounced inspection. Records include: inventory, order forms, invoices, dispensing, usage and disposal in testing, thefts & losses, power of attorney, and drug destructions.

l

SECURITY REQUIREMENTS - Covers stringent security requirements in order to prevent the diversion of any controlled substance.

l

SENDING DOCUMENTS TO DEA - Learn the methodology and requirements for mailing documents to the local DEA office.

Who will Benefit: Senior and mid-level Manager

l l

Scientists

l

Chemists registered with DEA as a Research Facility in a facility doing research with controlled substances.

Carlos M. Aquino brings 36 years of experience of handling illicit and pharmaceutical controlled substances and regulated chemicals. His testimonial ability, both in federal and state courts, is proof of his investigative experience and skills. Carlos has 12 years of experience working for Philadelphia DEA Diversion Group, which is responsible for initiating prosecutions of those DEA registrants who violate the federal Controlled Substances Act or DEA regulations pertaining to handling these substances. This has included eight years as a Diversion Investigator and four years as a Group Supervisor. During his time at the DEA, he performed numerous regulatory inspections of manufacturers, distributors, importers/exporters, physicians, researchers, and pharmacies in order to determine their compliance with the federal laws and DEA regulations pertaining to controlled substances in Schedules II through V and regulated chemicals. In addition to the above, Carlos has over 20 years of experience working for various law enforcement agencies including the Philadelphia Police. Carlos has a BA in Criminal Justice and has taught numerous courses during his time at the DEA. He is skilled in interpreting the Controlled Substances Act (CSA) and the Code of Federal Regulations (CFR), assisting the pharmaceutical industry with compliance, and preparing and submitting Drug Enforcement Administration (DEA) Forms 41, 104, 106, 222, 236, 486.

Update

Dr. Bradley A Dykstra Dentist, Hudsonville

Marianne H. Harper Director, The Art of Practice Management Susan E. Mazer President & CEO, Healing HealthCare Systems, Inc. More Speakers


Customer Reviews:No Reviews Yet. Â Be The First To Review This Webinar!

Related Webinars: No Related Webinars Available

Š2010 MentorHealth All rights reserved. Unauthorized use prohibited.

Web Analytics

FAQ Support Contact Us Feedback

Terms & Conditions Privacy Policy Unsubscribe

Speaker Opportunity Suggest a Topic Subscribe Newsletter


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.